Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
H
|
Huron Consulting Group Inc
XBER:HUR
|
US |
|
Fomento de Construcciones y Contratas SA
F:FCC0
|
ES |
|
Melrose Industries PLC
LSE:MRO
|
UK |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
|
Mizuho Financial Group Inc
SGX:N6DD
|
JP |
|
C
|
CECO Environmental Corp
NASDAQ:CECO
|
US |
|
Rexford Industrial Realty Inc
F:3I0
|
US |
|
SandRidge Energy Inc
NYSE:SD
|
US |
|
Medtronic PLC
NYSE:MDT
|
IE |
|
Keysight Technologies Inc
NYSE:KEYS
|
US |
|
P
|
PennantPark Floating Rate Capital Ltd
TASE:PFLT
|
US |
|
Apollo Global Management Inc
NYSE:APO
|
US |
|
AerSale Corp
NASDAQ:ASLE
|
US |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
T
|
Titanium Transportation Group Inc
TSX:TTNM
|
CA |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM1
|
ZA |
|
EOG Resources Inc
NYSE:EOG
|
US |
|
B
|
Basf Se
XBER:BAS
|
DE |
|
Custom Truck One Source Inc
NYSE:CTOS
|
US |
|
Ferrovial SE
AEX:FER
|
NL |
|
Rivian Automotive Inc
NASDAQ:RIVN
|
US |
|
B
|
Bank of China Ltd
DUS:W8V
|
CN |
|
I
|
Illumina Inc
F:ILU
|
US |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
